Evaluation of Lactobacillus delbrueckii Supernatant Effects on Cell CycleRegulation, Apoptosis Induction, and Gene Expression in HT-29 ColorectalCancer Cells

Document Type : Original Article

Authors
1 Department of Microbiology, Kaz.C, Islamic Azad University, Kazerun, Iran.
2  Department of Microbiology, Ja.C, Islamic Azad University, Jahrom, Iran.
3 Burn & Wound Healing Research Center, Shi.C, Shiraz, Iran.
Abstract
This study investigated the anti-tumor properties of Lactobacillus delbrueckii, a probiotic
bacterium, against HT
-29 human colorectal cancer cells.
The primary objective was to evaluate the effects of
Lactobacillus delbrueckii supernatant
on gene expression, cell viability, apoptosis, and cell cycle progression in HT
-29 cells. In
Gilan Province, Iran, a native strain of
Lactobacillus delbrueckii was identified from the
supernatant of local yogurt. After treating HT
-29 cells with different doses of the
supernatant, the MTT test was used to calculate the IC50 value 24 hours later. Annexin V/PI

staining and flow cytometry were used to evalu
ate the induction of apoptosis, and real-time
PCR was used to measure changes in gene expression. The results showed that the

supernatant of
Lactobacillus delbrueckii strongly and dose-dependently reduced the growth
of HT
-29 cells. In addition to causing apoptosis and stopping the cell cycle in the G0/G1
phase, the therapy also increased the number of Sub
-G1 cells, which is a sign of cell death.
According to gene expression study, anti
-apoptotic genes (AKT, Bcl-2) were
downregulated while pro
-apoptotic genes (PTEN, p53, and Bax) were upregulated.
Interestingly, the natural isolate outperformed a conventional strain in terms of anticancer

efficacy. These results demonstrate
Lactobacillus delbrueckii's potential as a colorectal
cancer treatment.

Keywords